Defective protein folding as a cause of disease
暂无分享,去创建一个
[1] P. Stein,et al. What do dysfunctional serpins tell us about molecular mobility and disease? , 1995, Nature Structural Biology.
[2] R. Crystal,et al. Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema. , 1981, The Journal of clinical investigation.
[3] J. Potempa,et al. The serpin superfamily of proteinase inhibitors: structure, function, and regulation. , 1994, The Journal of biological chemistry.
[4] J. Jeppsson. Amino acid substitution Glu→Lys in α1‐antitrypsin PiZ , 1976 .
[5] P. Pedersen,et al. Altered protein folding may be the molecular basis of most cases of cystic fibrosis , 1992, FEBS letters.
[6] A. Le,et al. Accumulation of the insoluble PiZ variant of human alpha 1-antitrypsin within the hepatic endoplasmic reticulum does not elevate the steady-state level of grp78/BiP. , 1990, The Journal of biological chemistry.
[7] G. Salvesen,et al. Human plasma proteinase inhibitors. , 1983, Annual review of biochemistry.
[8] R. Huber,et al. Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function. , 1984, Journal of molecular biology.
[9] D. Lomas,et al. Effect of the Z mutation on the physical and inhibitory properties of alpha 1-antitrypsin. , 1993, Biochemistry.
[10] T. Sveger. The Natural History of Liver Disease in (α1‐Antitrypsin Deficient Children , 1988 .
[11] Cliff,et al. Accumulation of PiZ alpha 1-antitrypsin causes liver damage in transgenic mice. , 1989, The Journal of clinical investigation.
[12] F. DeMayo,et al. Tissue specific expression of the human alpha-1-antitrypsin gene in transgenic mice. , 1987, Nucleic acids research.
[13] D. Johnson,et al. Structural evidence for methionine at the reactive site of human alpha-1-proteinase inhibitor. , 1978, The Journal of biological chemistry.
[14] D. Lomas,et al. The mechanism of Z α1-antitrypsin accumulation in the liver , 1993, Nature.
[15] J. Sambrook,et al. Protein folding in the cell , 1992, Nature.
[16] M. Finegold,et al. Alpha-1-antitrypsin deficiency: accumulation or degradation of mutant variants within the hepatic endoplasmic reticulum. , 1989, American journal of respiratory cell and molecular biology.
[17] Myeong-Hee Yu,et al. The Z type variation of human α1-antitrypsin causes a protein folding defect , 1995, Nature Structural Biology.
[18] K. E. Moore,et al. A lag in intracellular degradation of mutant alpha 1-antitrypsin correlates with the liver disease phenotype in homozygous PiZZ alpha 1-antitrypsin deficiency. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[19] R. Crystal,et al. Molecular basis of alpha-1-antitrypsin deficiency. , 1988, The American journal of medicine.
[20] A. Le,et al. Intracellular degradation of the transport-impaired human PiZ alpha 1-antitrypsin variant. Biochemical mapping of the degradative event among compartments of the secretory pathway. , 1990, The Journal of biological chemistry.
[21] A. Helenius,et al. Protein oligomerization in the endoplasmic reticulum. , 1989, Annual review of cell biology.
[22] W. Bode,et al. Structural aspects of serpin inhibition , 1994, FEBS letters.
[23] P. H. Cameron,et al. Association of folding intermediates of glycoproteins with calnexin during protein maturation , 1993, Nature.
[24] A. Le,et al. Association between calnexin and a secretion-incompetent variant of human alpha 1-antitrypsin. , 1994, The Journal of biological chemistry.
[25] A. Leslie,et al. Crystal structure of ovalbumin as a model for the reactive centre of serpins , 1990, Nature.
[26] R. Carrell,et al. Implications of the three-dimensional structure of alpha 1-antitrypsin for structure and function of serpins. , 1989, Biochemistry.